Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Goldenwell Biotech (GWLL) Return on Assets (2020 - 2025)

Goldenwell Biotech's Return on Assets history spans 6 years, with the latest figure at 0.09% for Q3 2025.

  • For Q3 2025, Return on Assets rose 74.0% year-over-year to 0.09%; the TTM value through Sep 2025 reached 0.09%, up 74.0%, while the annual FY2024 figure was 0.58%, 9.0% down from the prior year.
  • Return on Assets reached 0.09% in Q3 2025 per GWLL's latest filing, up from 0.02% in the prior quarter.
  • In the past five years, Return on Assets ranged from a high of 0.09% in Q3 2025 to a low of 5.36% in Q3 2023.
  • Average Return on Assets over 5 years is 1.19%, with a median of 0.35% recorded in 2022.
  • Peak YoY movement for Return on Assets: tumbled -501bps in 2023, then surged 470bps in 2024.
  • A 5-year view of Return on Assets shows it stood at 0.25% in 2021, then plummeted by -1433bps to 3.83% in 2022, then surged by 85bps to 0.56% in 2023, then skyrocketed by 68bps to 0.18% in 2024, then surged by 148bps to 0.09% in 2025.
  • Per Business Quant, the three most recent readings for GWLL's Return on Assets are 0.09% (Q3 2025), 0.02% (Q2 2025), and 0.19% (Q1 2025).